These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

738 related items for PubMed ID: 30145819

  • 1. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
    Lu PW, Li L, Wang F, Gu YT.
    J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819
    [Abstract] [Full Text] [Related]

  • 2. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
    Zhong JT, Yu J, Wang HJ, Shi Y, Zhao TS, He BX, Qiao B, Feng ZW.
    Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209
    [Abstract] [Full Text] [Related]

  • 3. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H, Pu J, Zhou XL, Ning YY, Bai C.
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [Abstract] [Full Text] [Related]

  • 4. YBX1/lncRNA SBF2-AS1 interaction regulates proliferation and tamoxifen sensitivity via PI3K/AKT/MTOR signaling in breast cancer cells.
    Hussain SA, Venkatesh T.
    Mol Biol Rep; 2023 Apr; 50(4):3413-3428. PubMed ID: 36754932
    [Abstract] [Full Text] [Related]

  • 5. Adipocyte-conditioned medium induces tamoxifen resistance by activating PI3K/Akt/mTOR pathway in estrogen receptor-positive breast cancer cells.
    Nakatsuji M, Fujimori K.
    Biochim Biophys Acta Mol Cell Res; 2024 Oct; 1871(7):119821. PubMed ID: 39159684
    [Abstract] [Full Text] [Related]

  • 6. Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway.
    Wu C, Luo J.
    Med Sci Monit; 2016 Oct 21; 22():3860-3867. PubMed ID: 27765938
    [Abstract] [Full Text] [Related]

  • 7. CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells.
    Nguyen Hoang AT, Hoe KL, Lee SJ.
    PLoS One; 2021 Oct 21; 16(4):e0246264. PubMed ID: 33861751
    [Abstract] [Full Text] [Related]

  • 8. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer.
    Li D, Ji H, Niu X, Yin L, Wang Y, Gu Y, Wang J, Zhou X, Zhang H, Zhang Q.
    Cancer Sci; 2020 Jan 21; 111(1):47-58. PubMed ID: 31710162
    [Abstract] [Full Text] [Related]

  • 9. Silencing of MicroRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells.
    Yu X, Li R, Shi W, Jiang T, Wang Y, Li C, Qu X.
    Biomed Pharmacother; 2016 Feb 21; 77():37-44. PubMed ID: 26796263
    [Abstract] [Full Text] [Related]

  • 10. Long non‑coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway.
    Li Z, Yu D, Li H, Lv Y, Li S.
    Int J Oncol; 2019 Mar 21; 54(3):1033-1042. PubMed ID: 30628639
    [Abstract] [Full Text] [Related]

  • 11. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J, Feng L, Tian C, Tang YL, Tang Y, Hu FQ.
    Eur Rev Med Pharmacol Sci; 2018 Dec 21; 22(23):8135-8144. PubMed ID: 30556851
    [Abstract] [Full Text] [Related]

  • 12. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.
    Chang HL, Sugimoto Y, Liu S, Wang LS, Huang YW, Ye W, Lin YC.
    Anticancer Res; 2009 Aug 21; 29(8):3195-205. PubMed ID: 19661335
    [Abstract] [Full Text] [Related]

  • 13. Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells.
    Chen YM, Liu Y, Wei HY, Lv KZ, Fu P.
    Tumour Biol; 2016 Aug 21; 37(8):10861-70. PubMed ID: 26883251
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of long non-coding RNA ROR reverses resistance to Tamoxifen by inducing autophagy in breast cancer.
    Li Y, Jiang B, Zhu H, Qu X, Zhao L, Tan Y, Jiang Y, Liao M, Wu X.
    Tumour Biol; 2017 Jun 21; 39(6):1010428317705790. PubMed ID: 28635401
    [Abstract] [Full Text] [Related]

  • 15. Long non-coding RNA FOXD3 antisense RNA 1 augments anti-estrogen resistance in breast cancer cells through the microRNA-363/ trefoil factor 1/ phosphatidylinositol 3-kinase/protein kinase B axis.
    Ren L, Zhou H, Lei L, Zhang Y, Cai H, Wang X.
    Bioengineered; 2021 Dec 21; 12(1):5266-5278. PubMed ID: 34424807
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of BAG‑1 in T47D cells promotes resistance to tamoxifen via activation of the PI3K/Akt/mTOR signaling pathway.
    Lu S, Du Y, Cui F, Feng X, Ma Y, Liu H.
    Oncol Rep; 2019 Mar 21; 41(3):1901-1910. PubMed ID: 30747221
    [Abstract] [Full Text] [Related]

  • 17. Long noncoding RNA H19 promotes chemotherapy resistance in choriocarcinoma cells.
    Yu S, Wu C, Tan Q, Liu H.
    J Cell Biochem; 2019 Sep 21; 120(9):15131-15144. PubMed ID: 31020694
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of Autophagy Increases Proliferation Inhibition and Apoptosis Induced by the PI3K/mTOR Inhibitor NVP-BEZ235 in Breast Cancer Cells.
    Ji Y, Di W, Yang Q, Lu Z, Cai W, Wu J.
    Clin Lab; 2015 Sep 21; 61(8):1043-51. PubMed ID: 26427150
    [Abstract] [Full Text] [Related]

  • 19. Luminal breast cancer cell lines overexpressing ZNF703 are resistant to tamoxifen through activation of Akt/mTOR signaling.
    Zhang X, Mu X, Huang O, Xie Z, Jiang M, Geng M, Shen K.
    PLoS One; 2013 Sep 21; 8(8):e72053. PubMed ID: 23991038
    [Abstract] [Full Text] [Related]

  • 20. Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.
    Ramaswamy B, Lu Y, Teng KY, Nuovo G, Li X, Shapiro CL, Majumder S.
    Cancer Res; 2012 Oct 01; 72(19):5048-59. PubMed ID: 22875023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.